Study finds that antibodies from people with the debilitating condition trigger similar symptoms in mice. Study finds that antibodies from people with the debilitating condition trigger similar symptoms in mice.
Donanemab slows progression of symptoms, but questions linger about the durability of its effect. Donanemab slows progression of symptoms, but questions linger about the durability of its effect.
Scientists race to design craft to reach the enigmatic 'Oumuamua astronomy.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from astronomy.com Daily Mail and Mail on Sunday newspapers.
Compound called lolamicin targets a group of harmful microbes but does not disturb those that live peacefully in the gut. Compound called lolamicin targets a group of harmful microbes but does not disturb those that live peacefully in the gut.